发帖
雷达卡
海量内容：
TABLE OF CONTENTS
ABOUT DATAMONITOR HEALTHCARE 2
About the Healthcare Strategic Analysis team 2
Executive Summary 3
Introduction 3
Strategic scoping and focus 4
Key findings – Healthcare drivers and resistors in China 5
Related reports 16
China – Socio-Demographic and Economic Analysis 19
China – Key findings 19
China – Demographic trends 21
China – Disease burden 27
China – Regional score card analysis 32
China – Political climate 47
China – Economic climate 50
China – Business environment 53
China – Healthcare System and Drug Regulatory Analysis 60
China – Key findings 60
China – Healthcare expenditure 63
China – Healthcare system 65
China – Health insurance 71
China – Regulatory issues 78
China – Pricing and reimbursement 93
China – Drug Expiry Analysis 106
China – Key findings 106
China – Generics market dynamics 108
China – Generics drivers and resistors 114
China – Key generics players 117
China – Biosimilar market dynamics 119
China – Pharmaceutical Industry Infrastructure Analysis 124
China – Key findings 124
China – Pharmaceutical industry infrastructure overview 125
Table of Contents
China Pharmaceutical Market Overview DMHC2648/ Published 11/2010
© Datamonitor. This report is a licensed product and is not to be photocopied Page 18
China – Key company infrastructure 131
China – Bibliography 165
China – Executive summary 165
China – Socio-demographic and Economic analysis 167
China – Healthcare system and drug regulation 173
China – Drug expiry analysis 179
China – Industry infrastructure analysis 182
Appendix 187
Exchange rates used in this report 187
About Datamonitor 188
Datamonitor - 2010 China Phar Market Overview.pdf
(2.59 MB, 需要: 7 个论坛币)
京公网安备 11010802022788号
